Researchers from the Hong Kong University of Science and Technology (HKUST) and Tongji University have developed FerroAI, a ...

Biotech company Zealand Pharma A/S, an innovator in peptide-based medicines, announced the positive topline results from its phase 3 trial of glepaglutide on Friday. A total of 106 patients with short ...

Bayer has added another phase 3 trial into its registration programme for oral Factor XIa inhibitor asundexian, signalling growing confidence in a drug that generated mixed results in phase 2. The new ...

Three fuel options, serious wattage, and smart engineering make this Generac one of the most capable backup power solutions I ...

Executives now expect to spend between $28 billion and $29 billion through 2028 and see opportunities for at least $4 billion worth of projects that aren’t yet in their plans.... Visibility gaps in ...